Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Initial Feasibility Study to Treat Pancreatic Cancer With a Planar LDR Source

Clinical Trial Title: 
Safety and efficacy of permanently implantable LDR CivaSheet® in combination with external beam radiation in the treatment of pancreatic cancer.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Dian Wang, MD, PhD
Clinical Trial Protocol Description: 

This is a feasibility study to determine the safety and efficacy of a new brachytherapy device that provides unidirectional radiation which utilizes active components (Palladium-103) of standard devices in a novel configuration. This pilot study may benefit pancreatic cancer patients by reducing the radiation dose to adjacent critical structures, while giving a therapeutic dose to diseased tissue, such as at a surgical margin. The appropriate dose and local control rate will be recorded the primary endpoint in order to provide an efficacy assessment.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are capable of undergoing anesthesia.
  • Have been selected to undergo Whipple procedure.
  • Do not have metastatic disease.
  • Have suspected R0 or R1 margins.
  • Have no prior radiation therapy to the region for separate cancer.
  • Have a confirmed diagnosis of borderline resectable or locally advanced pancreatic adenocarcinoma.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Gastrointestinal Cancers
Liver, Biliary and Pancreatic Disorders
Contact Phone: 
(312) 942-8892
Contact Name: 
Jean Gibson, RN, BSN